Stay updated on Expanded Access of Lifileucel in Melanoma: Clinical Trial
Sign up to get notified when there's something new on the Expanded Access of Lifileucel in Melanoma: Clinical Trial page.

Latest updates to the Expanded Access of Lifileucel in Melanoma: Clinical Trial page
- Check3 days agoChange DetectedThe page's revision tag was updated from v3.6.2 to v3.6.3, indicating a newer page version without changes to the displayed study information.SummaryDifference0.0%

- Check10 days agoChange DetectedThe page version tag was updated from Revision: v3.6.0 to Revision: v3.6.2. This reflects a maintenance/upgrade of the page rather than changes to study content or eligibility.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe update adds several help and navigation items (Check who can join, Find Contact Information, How to Read a Study Record, Common Questions, How to Join a Study) and adjusts the Intervention/Treatment heading formatting. It also updates the revision note from v3.5.5 to v3.6.0.SummaryDifference0.4%

- Check32 days agoChange DetectedThe page revision label was updated from v3.5.4 to v3.5.5, indicating a new version of the page. This reflects a minor internal update and does not alter the user-facing content.SummaryDifference0.0%

- Check53 days agoChange DetectedThe page revision was updated to v3.5.4, replacing the previous v3.5.3, signaling an update to the page content.SummaryDifference0.0%

- Check74 days agoChange DetectedThe study’s listed locations were updated, including adding additional participating centers such as South Austin Medical Center, Vanderbilt University, SCRI Oncology Partners, and others, along with changes to the displayed total number of U.S. locations. The page also shows updated record dates (e.g., last update submitted/posted) accompanying the location changes.SummaryDifference3%

Stay in the know with updates to Expanded Access of Lifileucel in Melanoma: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Expanded Access of Lifileucel in Melanoma: Clinical Trial page.